|
已选(0)清除
条数/页： 排序方式： |
| Preoperative CT-Based Radiomics Combined With Nodule Type to Predict the Micropapillary Pattern in Lung Adenocarcinoma of Size 2 cm or Less: A Multicenter Study 期刊论文
FRONTIERS IN ONCOLOGY, 2021, 卷号: 11
作者: Li, Meirong; Ruan, Yachao; Feng, Zhan; Sun, Fangyu; Wang, Minhong; Zhang, Liang
  收藏 | 浏览/下载：60/0 | 提交时间：2022/01/10
lung adenocarcinoma radiomics model micropapillary pattern (MPP) multicenter computed tomography |
| Prevalence and clinical significance of pathogenic germline BRCA1 2 mutations in Chinese non-small cell lung cancer patients 期刊论文
Cancer Biology & Medicine, 2019, 卷号: 16
作者: Hu Xingsheng; Yang Dongyong; Li Yalun; Li Li; Wang Yan; Chen Peng; Xu Song; Pu Xingxiang; Zhu Wei; Deng Pengbo; Yen Junyi; Zhang Hanhan; Lizaso Analyn; Liu Hao; Mao Xinru; Huang Hai; Chu Qian; Hu Chengping
收藏 | 浏览/下载：61/0 | 提交时间：2020/12/28
SUSCEPTIBILITY LOCUS PROSTATE-CANCER OVARIAN-CANCER BREAST RISK MULTICENTER EXPRESSION INHIBITORS VARIANTS CARRIERS Germline BRCA mutations non-small cell lung cancer prevalence BRCA1 BRCA2 |
| Exploratory clinical study of chidamide, an oral subtype-selective histone deacetylase inhibitor, in combination with exemestane in hormone receptor-positive advanced breast cancer 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2018, 卷号: 30
-
收藏 | 浏览/下载：34/0 | 提交时间：2020/10/26
PHASE-I POSTMENOPAUSAL WOMEN HDAC INHIBITOR MULTICENTER ENTINOSTAT TAMOXIFEN CS055/HBI-8000 RESISTANCE LETROZOLE TRIAL Advanced breast cancer hormone receptor-positive chidamide exemestane |
| Geriatric Assessment to Predict Survival and Risk of Serious Adverse Events in Elderly Newly Diagnosed Multiple Myeloma Patients: A Multicenter Study in China 期刊论文
CHINESE MEDICAL JOURNAL, 2017, 卷号: 130
-
收藏 | 浏览/下载：10/0 | 提交时间：2020/10/26
QUALITY-OF-LIFE METAANALYSIS THALIDOMIDE REGIMENS TRIALS Geriatric Assessment Multicenter Study Multiple Myeloma |
| Management of extramedullary plasmacytoma: Role of radiotherapy and prognostic factor analysis in 55 patients 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2017, 卷号: 29
-
收藏 | 浏览/下载：24/0 | 提交时间：2020/10/26
SOLITARY PLASMACYTOMA RADIATION-THERAPY CLINICAL-FEATURES ONCOLOGY-GROUP SOFT-TISSUE NECK HEAD BONE MULTICENTER GUIDELINES Extramedullary plasmacytoma prognostic factors radiotherapy multiple myeloma |
| Clinical characteristics and response to tyrosine kinase inhibitors of patients with non-small cell lung cancer harboring uncommon epidermal growth factor receptor mutations 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2017, 卷号: 29
-
收藏 | 浏览/下载：33/0 | 提交时间：2020/10/26
EGFR MUTATIONS GEFITINIB TREATMENT 1ST-LINE TREATMENT OPEN-LABEL RARE MULTICENTER ERLOTINIB GENE CHEMOTHERAPY EFFICACY Non-small cell lung cancer EGFR uncommon mutation target therapy |
| A Model Predicting Lymph Node Status for Patients with Clinical Stage T1aN0-2M0 Nonsmall Cell Lung Cancer 期刊论文
CHINESE MEDICAL JOURNAL, 2017, 卷号: 130
-
收藏 | 浏览/下载：29/0 | 提交时间：2020/10/26
POSITRON-EMISSION-TOMOGRAPHY COMPUTED-TOMOGRAPHY TUMOR SIZE PULMONARY RESECTION ESTS GUIDELINES METASTASIS ADENOCARCINOMA MULTICENTER INVOLVEMENT LOCATION Carcinoma Diagnosis Lymph Nodes Nonsmall Cell Lung Cancer Predictive Models |
| Effects of extended lymphadenectomy and postoperative chemotherapy on node-negative gastric cancer 期刊论文
WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 卷号: 19
-
收藏 | 浏览/下载：21/0 | 提交时间：2020/10/26
LYMPH-NODE PROGNOSTIC-SIGNIFICANCE PHASE-II RECURRENCE D2 GASTRECTOMY MULTICENTER METASTASIS SURVIVAL INDICATORS Gastric cancer Lymph node negative metastasis Extended lymphadenectomy D2 lymphadenectomy Chemotherapy |
| Chemotherapy with or without gefitinib in patients with advanced non-small-cell lung cancer: a meta-analysis of 6844 patients 期刊论文
CHINESE MEDICAL JOURNAL, 2013, 卷号: 126
-
收藏 | 浏览/下载：27/0 | 提交时间：2020/10/26
PHASE-III TRIAL PLATINUM-BASED CHEMOTHERAPY PREVIOUSLY TREATED PATIENTS JAPANESE PATIENTS RANDOMIZED-TRIAL SUPPORTIVE CARE NAIVE PATIENTS DOCETAXEL PLACEBO MULTICENTER non-small-cell-lung cancer gefitinib meta-analysis |
| Capecitabine combined with weekly docetaxel in Chinese patients > 65 years with anthracycline-resistant metastatic breast cancer 期刊论文
CHINESE MEDICAL JOURNAL, 2010, 卷号: 123
-
收藏 | 浏览/下载：26/0 | 提交时间：2020/10/26
PHASE-III TRIAL PLUS DOCETAXEL MULTICENTER THERAPY PHOSPHORYLASE TOLERABILITY PACLITAXEL XELODA(R) SURVIVAL capecitabine weekly docetaxel metastatic breast cancer anthracycline elderly tolerability |
